NCT00434668View on ClinicalTrials.gov

Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

September 30, 2010

Study Completion Date

November 30, 2010

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

cisplatin/docetaxel

DRUG

cisplatin/vinorelbine

Trial Locations (3)

2020

ZNA Middelheim, Antwerp

2610

St Augustinus ziekenhuis, Wilrijk

2650

University Hospital Antwerp, Edegem

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

collaborator

Sanofi

INDUSTRY

lead

University Hospital, Antwerp

OTHER